Stem Cells Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
Conditions:   Allogeneic Hematopoietic Stem Cell Transplantation;   Allogeneic Stem Cell Transplantation;   Hematologic Malignancies Interventions:   Drug: Fludarabine;   Drug: Melphalan;   Radiation: Total Body Irradiation Sponsor:   University of California, Irvine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials